Research has demonstrated that OPN is involved in several neurological conditions, including MS [112,113], Parkinson’s disease [114], AD [40,115], and other neurodegenerative disorders, while also promoting the progression of these diseases [116]. Here, SPP1 is linked to myeloid sarcoma.